FOAMIX PHARMACEUTICALS LTD's ticker is FOMX and the CUSIP is M46135105. A total of 67 filers reported holding FOAMIX PHARMACEUTICALS LTD in Q4 2018. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,550,000 | +11.0% | 680,000 | +6.2% | 0.05% | +6.5% |
| Q4 2018 | $2,298,000 | -68.7% | 640,000 | -50.0% | 0.05% | -48.9% |
| Q3 2018 | $7,334,000 | +275.3% | 1,280,000 | +228.2% | 0.09% | +136.8% |
| Q2 2018 | $1,954,000 | -47.8% | 390,000 | -46.5% | 0.04% | -2.6% |
| Q1 2018 | $3,740,000 | +130.4% | 729,000 | +170.0% | 0.04% | +105.3% |
| Q4 2017 | $1,623,000 | +71.9% | 270,000 | +58.8% | 0.02% | +58.3% |
| Q3 2017 | $944,000 | – | 170,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|